Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Acquired brain injury in the fetus and newborn [[electronic resource] /] / Michael Shevell, Steven Miller
| Acquired brain injury in the fetus and newborn [[electronic resource] /] / Michael Shevell, Steven Miller |
| Autore | Shevell Michael |
| Pubbl/distr/stampa | Cambridge, : Mac Keith Press, : [distributor] John Wiley and Sons Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons, 2012 |
| Descrizione fisica | 1 online resource (340 p.) |
| Disciplina | 618.3/2 |
| Altri autori (Persone) | MillerSteven |
| Collana | 1st |
| Soggetto topico |
Fetal brain - Diseases
Newborn infants - Wounds and injuries |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-907655-36-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Authors' Appointments; Foreword; Preface; Acknowledgments; 1 Brain Injury in the Fetus; Introduction; Overview of normal fetal brain development; Normal function of the maternal placenta-fetal interface; Mechanisms of fetal brain injury; Fetal errors of metabolism; Conclusions; 2 Imaging the Fetal Brain; Introduction; Imaging the fetal brain: ultrasound versus magnetic resonance imaging; Imaging the fetal brain: the role of conventional magnetic resonance imaging; Normal fetal brain development on conventional magnetic resonance imaging
Fetal brain injury in the fetus on conventional magnetic resonance imaging Advanced magnetic resonance imaging techniques in the ex utero infant; Acquired fetal brain injury and advanced in vivo fetal magnetic resonance imaging techniques; Summary; 3 Mechanisms of Acute and Chronic Brain Injury in the Preterm Infant ; Magnitude of the problem and spectrum of brain injury in preterm survivors; Patholologic features of brain injury in preterm infants; Pathophysiology of cerebral white matter injury; Cellular-molecular mechanisms of acute whitematter injury Cellular mechanisms of chronic white matter injury: myelination failure and the susceptibility of oligodendrocytes and axons Is acquired chronic brain injury in preterm infants necessarily static and irreparable?; Clinical implications of potentially arrested white matter development; 4 Clinical assessment of the Preterm Infant including Near-infrared spectroscopy, amplitude-integrated Electroencephalography, and Electroencephalography; Near-infrared spectroscopy-monitored regional cerebral oxygen saturation; Electroencephalography and amplitude-integratedEEG; Conclusion 5 Imaging the Brain of the Preterm Infant Introduction; Magnetic resonance imaging of the brain in the normal preterm infant; Magnetic resonance imaging of brain injury in the preterm infant; Quantitative magnetic resonance studies of the developing brain in the preterm infant and association with neurodevelopmental outcome; 6 Protecting the Brain of the Preterm Infant; Introduction; Intraventricular hemorrhage; Posthemorrhagic ventricular dilation; White matter injury; Cerebellar injury; Antenatal neuroprotective agents; Developmental care and nutrition Emerging candidates for future neuroprotective investigations Conclusions; 7 Seizures in the Preterm Infant; Introduction; Epidemiology; Clinical features; Differential diagnosis; Investigations including imaging; Treatment and management; Short- and long-term outcomes; Implications for future research; 8 Outcomes After Brain Injury in the Preterm Infant; Motor impairment; Cognitive impairment; Behavioral and psychiatric disorders; Conclusion; 9 Mechanisms of Brain Neurodegeneration in the Term Infant; Introduction; Types of cell death Molecular and cellular mechanisms of cell death in the immature brain |
| Record Nr. | UNINA-9910462670303321 |
Acquired brain injury in the fetus and newborn [[electronic resource] /] / Michael Shevell, Steven Miller
| Acquired brain injury in the fetus and newborn [[electronic resource] /] / Michael Shevell, Steven Miller |
| Autore | Shevell Michael |
| Pubbl/distr/stampa | Cambridge, : Mac Keith Press, : [distributor] John Wiley and Sons Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons, 2012 |
| Descrizione fisica | 1 online resource (340 p.) |
| Disciplina | 618.3/2 |
| Altri autori (Persone) | MillerSteven |
| Collana | 1st |
| Soggetto topico |
Fetal brain - Diseases
Newborn infants - Wounds and injuries |
| ISBN | 1-907655-36-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Authors' Appointments; Foreword; Preface; Acknowledgments; 1 Brain Injury in the Fetus; Introduction; Overview of normal fetal brain development; Normal function of the maternal placenta-fetal interface; Mechanisms of fetal brain injury; Fetal errors of metabolism; Conclusions; 2 Imaging the Fetal Brain; Introduction; Imaging the fetal brain: ultrasound versus magnetic resonance imaging; Imaging the fetal brain: the role of conventional magnetic resonance imaging; Normal fetal brain development on conventional magnetic resonance imaging
Fetal brain injury in the fetus on conventional magnetic resonance imaging Advanced magnetic resonance imaging techniques in the ex utero infant; Acquired fetal brain injury and advanced in vivo fetal magnetic resonance imaging techniques; Summary; 3 Mechanisms of Acute and Chronic Brain Injury in the Preterm Infant ; Magnitude of the problem and spectrum of brain injury in preterm survivors; Patholologic features of brain injury in preterm infants; Pathophysiology of cerebral white matter injury; Cellular-molecular mechanisms of acute whitematter injury Cellular mechanisms of chronic white matter injury: myelination failure and the susceptibility of oligodendrocytes and axons Is acquired chronic brain injury in preterm infants necessarily static and irreparable?; Clinical implications of potentially arrested white matter development; 4 Clinical assessment of the Preterm Infant including Near-infrared spectroscopy, amplitude-integrated Electroencephalography, and Electroencephalography; Near-infrared spectroscopy-monitored regional cerebral oxygen saturation; Electroencephalography and amplitude-integratedEEG; Conclusion 5 Imaging the Brain of the Preterm Infant Introduction; Magnetic resonance imaging of the brain in the normal preterm infant; Magnetic resonance imaging of brain injury in the preterm infant; Quantitative magnetic resonance studies of the developing brain in the preterm infant and association with neurodevelopmental outcome; 6 Protecting the Brain of the Preterm Infant; Introduction; Intraventricular hemorrhage; Posthemorrhagic ventricular dilation; White matter injury; Cerebellar injury; Antenatal neuroprotective agents; Developmental care and nutrition Emerging candidates for future neuroprotective investigations Conclusions; 7 Seizures in the Preterm Infant; Introduction; Epidemiology; Clinical features; Differential diagnosis; Investigations including imaging; Treatment and management; Short- and long-term outcomes; Implications for future research; 8 Outcomes After Brain Injury in the Preterm Infant; Motor impairment; Cognitive impairment; Behavioral and psychiatric disorders; Conclusion; 9 Mechanisms of Brain Neurodegeneration in the Term Infant; Introduction; Types of cell death Molecular and cellular mechanisms of cell death in the immature brain |
| Record Nr. | UNINA-9910786293303321 |
Shevell Michael
|
||
| Cambridge, : Mac Keith Press, : [distributor] John Wiley and Sons Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Acquired brain injury in the fetus and newborn [[electronic resource] /] / Michael Shevell, Steven Miller
| Acquired brain injury in the fetus and newborn [[electronic resource] /] / Michael Shevell, Steven Miller |
| Autore | Shevell Michael |
| Pubbl/distr/stampa | Cambridge, : Mac Keith Press, : [distributor] John Wiley and Sons Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons, 2012 |
| Descrizione fisica | 1 online resource (340 p.) |
| Disciplina | 618.3/2 |
| Altri autori (Persone) | MillerSteven |
| Collana | 1st |
| Soggetto topico |
Fetal brain - Diseases
Newborn infants - Wounds and injuries |
| ISBN | 1-907655-36-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Authors' Appointments; Foreword; Preface; Acknowledgments; 1 Brain Injury in the Fetus; Introduction; Overview of normal fetal brain development; Normal function of the maternal placenta-fetal interface; Mechanisms of fetal brain injury; Fetal errors of metabolism; Conclusions; 2 Imaging the Fetal Brain; Introduction; Imaging the fetal brain: ultrasound versus magnetic resonance imaging; Imaging the fetal brain: the role of conventional magnetic resonance imaging; Normal fetal brain development on conventional magnetic resonance imaging
Fetal brain injury in the fetus on conventional magnetic resonance imaging Advanced magnetic resonance imaging techniques in the ex utero infant; Acquired fetal brain injury and advanced in vivo fetal magnetic resonance imaging techniques; Summary; 3 Mechanisms of Acute and Chronic Brain Injury in the Preterm Infant ; Magnitude of the problem and spectrum of brain injury in preterm survivors; Patholologic features of brain injury in preterm infants; Pathophysiology of cerebral white matter injury; Cellular-molecular mechanisms of acute whitematter injury Cellular mechanisms of chronic white matter injury: myelination failure and the susceptibility of oligodendrocytes and axons Is acquired chronic brain injury in preterm infants necessarily static and irreparable?; Clinical implications of potentially arrested white matter development; 4 Clinical assessment of the Preterm Infant including Near-infrared spectroscopy, amplitude-integrated Electroencephalography, and Electroencephalography; Near-infrared spectroscopy-monitored regional cerebral oxygen saturation; Electroencephalography and amplitude-integratedEEG; Conclusion 5 Imaging the Brain of the Preterm Infant Introduction; Magnetic resonance imaging of the brain in the normal preterm infant; Magnetic resonance imaging of brain injury in the preterm infant; Quantitative magnetic resonance studies of the developing brain in the preterm infant and association with neurodevelopmental outcome; 6 Protecting the Brain of the Preterm Infant; Introduction; Intraventricular hemorrhage; Posthemorrhagic ventricular dilation; White matter injury; Cerebellar injury; Antenatal neuroprotective agents; Developmental care and nutrition Emerging candidates for future neuroprotective investigations Conclusions; 7 Seizures in the Preterm Infant; Introduction; Epidemiology; Clinical features; Differential diagnosis; Investigations including imaging; Treatment and management; Short- and long-term outcomes; Implications for future research; 8 Outcomes After Brain Injury in the Preterm Infant; Motor impairment; Cognitive impairment; Behavioral and psychiatric disorders; Conclusion; 9 Mechanisms of Brain Neurodegeneration in the Term Infant; Introduction; Types of cell death Molecular and cellular mechanisms of cell death in the immature brain |
| Record Nr. | UNINA-9910809293703321 |
|
Shevell Michael
|
||
| Cambridge, : Mac Keith Press, : [distributor] John Wiley and Sons Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons Australia Ltd, : [distributor] John Wiley & Sons, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Congenital Malformations [[electronic resource]]
| Congenital Malformations [[electronic resource]] |
| Autore | Symposium CIBA Foundation |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2009 |
| Descrizione fisica | 1 online resource (322 p.) |
| Disciplina |
618.3/2
618.32 |
| Collana | Novartis Foundation Symposia |
| Soggetto topico |
Abnormalities, Human -- Diagnosis
Abnormalities, Human -- Treatment Congenital Abnormalities -- diagnosis Congenital Abnormalities -- therapy Evidence-based medicine Genetic Counseling Genetic Diseases, Inborn -- therapy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-470-71527-8
0-470-71495-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
CIBA FOUNDATION SYMPOSIUM ON CONGENITAL MALFORMATIONS; PREFACE; CONTENTS; Chairman's Opening Remarks; Malformations in a population observed for five years after birth; Discussion; Genetical causes of malformation and the search for their origins; Discussion; Chromosomal abnormality and congenital malformation; Discussion; Environmental factors in causation of congenital anomalies; Discussion; Teratogenic effects of tumour-inhibiting chemicals in the foetal rat; Discussion; The teratogenic action of the antibiotic actinomycin D; Discussion
Teratogenic effects of pteroylglutamic acid deficiency in the ratDiscussion; The modification of the activity of certain agents exerting a deleterious effect on the development of the mammalian embryo; Discussion; Congenital runts; Discussion; Causes and morphogenesis of anencephaly; Discussion; Causes of congenital malformations: rôle of prediabetes and hypothyroidism; Discussion; The association of hydramnios with congenital malforma- tions; Discussion; General Discussion; INDEX OF AUTHORS; SUBJECT INDEX |
| Record Nr. | UNINA-9910144670303321 |
|
Symposium CIBA Foundation
|
||
| Hoboken, : Wiley, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Congenital Malformations [[electronic resource]]
| Congenital Malformations [[electronic resource]] |
| Autore | Symposium CIBA Foundation |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2009 |
| Descrizione fisica | 1 online resource (322 p.) |
| Disciplina |
618.3/2
618.32 |
| Collana | Novartis Foundation Symposia |
| Soggetto topico |
Abnormalities, Human -- Diagnosis
Abnormalities, Human -- Treatment Congenital Abnormalities -- diagnosis Congenital Abnormalities -- therapy Evidence-based medicine Genetic Counseling Genetic Diseases, Inborn -- therapy |
| ISBN |
0-470-71527-8
0-470-71495-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
CIBA FOUNDATION SYMPOSIUM ON CONGENITAL MALFORMATIONS; PREFACE; CONTENTS; Chairman's Opening Remarks; Malformations in a population observed for five years after birth; Discussion; Genetical causes of malformation and the search for their origins; Discussion; Chromosomal abnormality and congenital malformation; Discussion; Environmental factors in causation of congenital anomalies; Discussion; Teratogenic effects of tumour-inhibiting chemicals in the foetal rat; Discussion; The teratogenic action of the antibiotic actinomycin D; Discussion
Teratogenic effects of pteroylglutamic acid deficiency in the ratDiscussion; The modification of the activity of certain agents exerting a deleterious effect on the development of the mammalian embryo; Discussion; Congenital runts; Discussion; Causes and morphogenesis of anencephaly; Discussion; Causes of congenital malformations: rôle of prediabetes and hypothyroidism; Discussion; The association of hydramnios with congenital malforma- tions; Discussion; General Discussion; INDEX OF AUTHORS; SUBJECT INDEX |
| Record Nr. | UNINA-9910830505703321 |
|
Symposium CIBA Foundation
|
||
| Hoboken, : Wiley, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Congenital Malformations [[electronic resource]]
| Congenital Malformations [[electronic resource]] |
| Autore | Symposium CIBA Foundation |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2009 |
| Descrizione fisica | 1 online resource (322 p.) |
| Disciplina |
618.3/2
618.32 |
| Collana | Novartis Foundation Symposia |
| Soggetto topico |
Abnormalities, Human -- Diagnosis
Abnormalities, Human -- Treatment Congenital Abnormalities -- diagnosis Congenital Abnormalities -- therapy Evidence-based medicine Genetic Counseling Genetic Diseases, Inborn -- therapy |
| ISBN |
0-470-71527-8
0-470-71495-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
CIBA FOUNDATION SYMPOSIUM ON CONGENITAL MALFORMATIONS; PREFACE; CONTENTS; Chairman's Opening Remarks; Malformations in a population observed for five years after birth; Discussion; Genetical causes of malformation and the search for their origins; Discussion; Chromosomal abnormality and congenital malformation; Discussion; Environmental factors in causation of congenital anomalies; Discussion; Teratogenic effects of tumour-inhibiting chemicals in the foetal rat; Discussion; The teratogenic action of the antibiotic actinomycin D; Discussion
Teratogenic effects of pteroylglutamic acid deficiency in the ratDiscussion; The modification of the activity of certain agents exerting a deleterious effect on the development of the mammalian embryo; Discussion; Congenital runts; Discussion; Causes and morphogenesis of anencephaly; Discussion; Causes of congenital malformations: rôle of prediabetes and hypothyroidism; Discussion; The association of hydramnios with congenital malforma- tions; Discussion; General Discussion; INDEX OF AUTHORS; SUBJECT INDEX |
| Record Nr. | UNINA-9910841196703321 |
|
Symposium CIBA Foundation
|
||
| Hoboken, : Wiley, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs during pregnancy [[electronic resource] /] / Bengt Källén
| Drugs during pregnancy [[electronic resource] /] / Bengt Källén |
| Autore | Källén Bengt |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (464 p.) |
| Disciplina | 618.3/2 |
| Collana | Pregnancy and infants : medical, psychological and social issues series |
| Soggetto topico |
Fetus - Effect of drugs on
Pregnant women - Drug use |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61728-374-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910460022203321 |
|
Källén Bengt
|
||
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs during pregnancy [[electronic resource] /] / Bengt Källén
| Drugs during pregnancy [[electronic resource] /] / Bengt Källén |
| Autore | Källén Bengt |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (464 p.) |
| Disciplina | 618.3/2 |
| Collana | Pregnancy and infants : medical, psychological and social issues series |
| Soggetto topico |
Fetus - Effect of drugs on
Pregnant women - Drug use |
| ISBN | 1-61728-374-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910785180203321 |
|
Källén Bengt
|
||
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs during pregnancy [[electronic resource] /] / Bengt Källén
| Drugs during pregnancy [[electronic resource] /] / Bengt Källén |
| Autore | Källén Bengt |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Nova Biomedical Books, c2009 |
| Descrizione fisica | 1 online resource (464 p.) |
| Disciplina | 618.3/2 |
| Collana | Pregnancy and infants : medical, psychological and social issues series |
| Soggetto topico |
Fetus - Effect of drugs on
Pregnant women - Drug use |
| ISBN | 1-61728-374-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Abbreviations Used -- Chapter 1 -- A Short history of the study of maternal drug Use and delivery outcome -- The alert clinician -- Epidemiological studies -- References -- Chapter 2 -- The practical consequences of drug effects on delivery outcome -- 1. Introduction of a New drug into a market -- 2. A woman has Used the drug in early pregnancy -- 3. To prescribe a drug to a pregnant woman -- 4. A malformed infant was born and the mother remembers Having Taken a specific drug. -- A causal effect? -- Chapter 3 -- The Swedish health registers used and variables studied -- The following records are included: -- MHV1 -- MHV2 -- FV1 -- FV2 -- The following data were used -- Year of delivery -- Maternal age -- Parity -- Smoking in early pregnancy -- Number of previous miscarriages -- Body Mass Index (BMI) -- Country of birth -- Family situation -- Work outside home -- Maternal education -- Maternal drug use -- Multiple births -- Maternal delivery diagnoses -- Delivery mode -- Pregnancy duration in completed weeks -- Infant sex -- Birth weight in gram -- Intrauterine growth -- Infant neonatal diagnoses -- Low Apgar score -- Congenital malformations in infants -- Any congenital malformation -- Chapter 4 -- Advantages and disadvantages of the study material -- Advantages -- Disadvantages -- Exposure information -- Outcome information -- Information on confounding factors -- References -- Chapter 5 -- Strategy of analysis -- Statistical notes -- References -- Chapter 6 -- Data on women and infants recorded in the Medical Birth Register during -- 1996-2005 -- Data on pregnancy outcome in all deliveries in the Medical Birth Register during 1996-2005 -- 1. Preterm birth, low birth weight, large birth weight, intrauterine growth -- 2. Infant sex and multiple births.
3. Maternal and infant diagnoses and infant outcome -- 4. Congenital malformations -- Chapter 7 -- Antacids -- Characteristics of women Using antacids -- Outcome after maternal Use of antacids -- Infant sex -- Multiple births -- Summary -- References -- Chapter 8 -- Drugs Used for gastric ulcer and gastro-oesophageal reflux -- Characteristics of women Using drugs for gastric ulcer or gastro-oesophageal reflux -- Outcome after maternal Use of drugs for stomach ulcer or gastro-oesophageal reflux -- Infant sex -- Multiple births -- Sucralfate -- Effects of concomitant drug use -- Summary -- References -- Chapter 9 -- Drugs Used for functional intestinal symptoms -- Characteristics of women Using drugs for functional intestinal symptoms -- Outcome after maternal Use of drugs for functional intestinal symptoms -- Infant sex -- Multiple births -- Summary -- References -- Chapter 10 -- Anti-Emetic drugs -- Outcome after maternal Use of antiemetic drugs -- Infant sex -- Multiple births -- Summary -- References -- Chapter 11 -- Bile acid preparations -- Outcome after maternal Use of Bile Acid preparations -- Infant sex -- Multiple birth -- Infant mortality -- Summary -- Chapter 12 -- Laxatives -- Characteristics of women Using laxatives -- Outcome after maternal Use of laxatives -- Infant sex -- Multiple births -- Summary -- References -- Chapter 13 -- Drugs Used as antidiarrhoics, intestinal anti-Infectives, or at inflammatory bowel disease -- Characteristics for women Using drugs as antidiarrhoics, intestinal anti-infectives, or at inflammatory bowel disease -- Outcome after maternal use of drugs Used as antidiarrhoics, intestinal anti-infectives, or at inflammatory bowel disease -- Infant sex -- Multiple births -- Summary -- References -- Chapter 14 -- Anti-Obesity drugs -- Characteristics of women Using anti-Obesity drugs. Outcome after maternal Use of anti-Obesity drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 15 -- Digestives, including enzymes -- Characteristics of women Using digestive drugs -- Outcome after maternal Use of digestive drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 16 -- Drugs for diabetes -- Characteristics of women Using antidiabetic drugs -- Outcome after maternal Use of antidiabetic drugs -- Infant sex -- Multiple births -- Summary -- References -- Chapter 17 -- Vitamins and minerals -- Characteristics of women Using vitamins or minerals -- Outcome after maternal Use of vitamins and minerals -- Infant sex -- Multiple births -- Summary -- References -- Chapter 18 -- Anabolic steroids -- Summary -- References -- Chapter 19 -- Anticoagulants -- Characteristics of women Using anticoagulant drugs -- Outcome after maternal Use of anticoagulants -- Infant sex -- Multiple births -- Summary -- References -- Chapter 20 -- Haemostatics -- Characteristics of women Using Haemostatics -- Outcome after maternal Use of haemostatics -- Infant sex -- Multiple births -- Infant mortality -- K-vitamin -- Summary -- References -- Chapter 21 -- Vitamin B12 and folic acid -- Characteristics of women Using vitamin B12 or folic acid -- Outcome after maternal Use of vitamin B12 or folic acid -- Infant sex -- Multiple births -- Summary -- References -- Chapter 22 -- Drugs for cardiac diseases -- Characteristics of women Using drugs for cardiac diseases -- Outcome after maternal Use of cardiac drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 23 -- Antihypertensives -- Characteristics of women Using drugs for antihypertensives -- Outcome after maternal Use of antihypertensives -- Infant sex -- Multiple births -- Summary. References -- Chapter 24 -- Diuretics -- Characteristics of women Using diuretics -- Outcome after maternal Use of diuretics -- Infant sex -- Multiple births -- Summary -- References -- Chapter 25 -- Serum lipid reducing agents -- Characteristics of women Using lipid reducing drugs -- Outcome after maternal Use of lipid reducing drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 26 -- Dermatological drugs -- Characteristics of women Using dermatological drugs -- Outcome after maternal Use of dermatological drugs -- Infant sex -- Multiple births -- Topical corticosteroids -- Other dermatological drugs -- Summary -- References -- Chapter 27 -- Gynaecological drugs -- Characteristics of women Using anti-infectives or antiseptics vaginally -- Outcome after maternal Use of anti-infectives or antiseptics vaginally -- Infant sex -- Multiple births -- Summary -- References -- Chapter 28 -- Prolactine inhibitors and dopamine agonists -- Characteristics of women Using prolactine inhibitors or dopamine agonists -- Outcome after maternal Use of prolactine inhibitors or dopamine agonists -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 29 -- Oral contraceptives -- Characteristics of women Using oral contraceptives in early pregnancy -- Outcome after maternal Use of oral contraceptives in early pregnancy -- Infant sex -- Multiple births -- Summary -- References -- Chapter 30 -- Sex hormones Other than oral contraceptives -- Characteristics of women Using progestogen drugs -- Outcome after maternal Use of progestogens -- Infant sex -- Multiple births -- Summary -- References -- Chapter 31 -- Ovulation stimulants -- Characteristics of women Using ovarian stimulants -- Outcome after maternal Use of ovarian stimulants -- Infant sex -- Multiple births -- Summary -- References. Chapter 32 -- Urologicals -- Characteristics of women using urological drugs -- Outcome after maternal Use of urologics -- Infant sex -- Multiple births -- Summary -- Chapter 33 -- Hypophyseal and hypothalamic hormones (except gonadotrophines) and analogues -- Characteristics of women Using hypophyseal or hypothalamic drugs -- Outcome after maternal Use of hypophyseal hormones other than gonadotrophines -- Infant sex -- Multiple births -- Summary -- References -- Chapter 34 -- Corticosteroids Used systemically -- Characteristics of women Using glucocorticoids -- Outcome after maternal Use of glucocorticosteroids -- Infant sex -- Multiple births -- Summary -- References -- Chapter 35 -- Thyroid drugs -- Characteristics of women Using thyroid drugs -- Thyroid hormones -- Thyreostatics -- Outcome after maternal Use of thyroid drugs -- Infant sex -- Multiple births -- Summary -- References -- Chapter 36 -- Antibiotics Used systemically -- Characteristics of women Using antibiotics -- Outcome after maternal Use of antibiotics -- Infant sex -- Multiple births -- Trimethoprim -- Quinolone derivatives -- Summary -- References -- Chapter 37 -- Antimycotics Used systemically -- Characteristics of women Using systemic antimycotics -- Outcome after maternal Use of systemic antimycotics -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 38 -- Tuberculostatic drugs -- Characteristics of women Using tuberculostatic drugs -- Outcome after maternal Use of tuberculostatic drugs -- Infant sex -- Multiple births -- Infant mortality -- Pregnancy duration and infant birth weight at maternal use of tuberculostatic drugs -- Summary -- References -- Chapter 39 -- Anti-Virus drugs -- Characteristics of women Using antivirus drugs -- Outcome after maternal Use of antivirus drugs -- Infant sex -- Multiple births -- Summary -- References. Chapter 40. |
| Record Nr. | UNINA-9910810938703321 |
|
Källén Bengt
|
||
| New York, : Nova Biomedical Books, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs for pregnant and lactating women / / Carl P. Weiner, Clifford Mason
| Drugs for pregnant and lactating women / / Carl P. Weiner, Clifford Mason |
| Autore | Weiner Carl P. |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Philadelphia, PA : , : Elsevier, , [2019] |
| Descrizione fisica | 1 online resource (1,027 pages) |
| Disciplina | 618.3/2 |
| Soggetto topico |
Pregnancy - Effect of drugs on
Breastfeeding - Effect of drugs on Fetus - Effect of drugs on Newborn infants - Effect of drugs on Obstetrical pharmacology Drugs - Side effects Pregnancy - drug effects Breast Feeding - adverse effects Contraindications Drug-Related Side Effects and Adverse Reactions Fetus - drug effects Pharmaceutical Preparations Pregnancy Complications - chemically induced Infant |
| Soggetto genere / forma | Handbook |
| ISBN | 0-323-50870-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583310803321 |
|
Weiner Carl P.
|
||
| Philadelphia, PA : , : Elsevier, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
